SLNO Stock Analysis: Buy, Sell, or Hold?
SLNO - Soleno Therapeutics, Inc. Common Stock
$53.01
0.02 (0.04%)
▲
5d:
+0.11%
30d:
+0.84%
90d:
+42.35%
HOLD
MODERATE Confidence
Analysis Updated: May 15, 2026 12:00 AM ET
Earnings: May 06, 2026
0d
Smart Money Accumulation
None View Scanner →
Strength: 4.7/10
Get Alerted When SLNO Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
📊 HOLD: SLNO shows mixed signals. Fine to hold existing positions. Not urgent to buy or sell.
📊 HOLD: SLNO shows mixed signals. Fine to hold existing positions. Not urgent to buy or sell.
Long-Term Wealth Forecast (2031)
Based on Analyst Consensus Growth & Historical Valuation
0% (Stagnation)
50% (Hyper Growth)
EST. PRICE IN 2031
$108.93
Based on 14.5% avg growth
INTRINSIC VALUE TODAY
$67.64
21.6% Margin of Safety
How this is calculated: We use a Growth Decay Model: starting with analyst consensus growth (adjusted above) and gradually slowing it down to a long-term terminal rate (4%) by Year 5. This provides a more realistic valuation than assuming constant hyper-growth. We then apply a 8.9x Exit PE.
In-depth Analysis How we analyze
Valuation Analysis: SLNO is currently trading at $53.01, which is considered extended relative to its 30-day fair value range of $52.57 to $52.94. The stock's valuation (Forward PE: 8.4) is in line with its historical norms (8.9). Remarkably, the market is currently pricing in an annual earnings decline of 1.8% over the next few years. This aligns with recent fundamental challenges.
Technical Outlook: Technically, SLNO is in a uptrend. The price is currently testing key support at $52.84. A bounce from this level would confirm strength, while a break below could signal further downside.
Market Sentiment: The stock shows a mixed technical setup (40/100), with neutral trendline and momentum signals. The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Technical Outlook: Technically, SLNO is in a uptrend. The price is currently testing key support at $52.84. A bounce from this level would confirm strength, while a break below could signal further downside.
Market Sentiment: The stock shows a mixed technical setup (40/100), with neutral trendline and momentum signals. The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Quick Decision Summary
Current Position
EXTENDED
Historical Trading Range
$52.57 -
$52.94
Company Quality Score
49/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
46.2%
Protect Your Profits
SLNO is technically overbought (RSI 78). Consider hedging now to protect against a potential pullback while keeping your upside.
View Profit Protection PlanAll Signals
- BEARISH: Price extended above range
- NEUTRAL: Mixed technical signals (40/100)
- BULLISH: High volume confirmation
- NEUTRAL: Near Wall St target ($53.00)
Trading Range Analysis
30-Day Trading Range
$52.57 -
$52.94
Current vs Trading Range
EXTENDED
Support & Resistance Levels
Support Level
$52.84
Resistance Level
$53.00
Current Trend
Uptrend
Technical data as of
May 15, 2026
Fundamental Context
Forward P/E (Next Year Est.)
8.43
Wall Street Target
$53.00
Profit Margin
33.7%
Valuation Discount vs History
-1.8% cheaper
PE vs Historical
8.4 vs 8.9
FAIR
Market-Implied Price Targets
If current PE multiple persists
Implied Growth (YoY):
-1.8%
(market-implied from PE analysis)
1-Year Target
$52.06
(-2%)
2-Year Target
$51.12
(-4%)
3-Year Target
$50.20
(-5%)
3-Yr Target (if PE normalizes)
(PE: 8→9)
$52.97
(0%)
3-Year Scenarios
Using analyst projected EPS growth
Bull:
(PE: 22.1, Growth: 59.2%)
$468.15
(+783%)
Base:
(SPY PE: 8.4, Growth: 59.2%)
$178.91
(+238%)
Bear:
(PE: 7.2, Growth: 59.2%)
$152.07
(+187%)
📈
Valuation based on Current Earnings
RECOVERY PLAY: Stock looks expensive now (27x PE), but valuation improves significantly next year (8x PE) as earnings recover.
Trailing PE: 27.46 | Current EPS (TTM): $1.93
Bull Case
$116.58
(+120%)
Analyst growth 100.0%, PE expands to 30.2
Base Case
$105.98
(+100%)
Market implied 100.0%, PE stable at 27.5
Bear Case
$36.03
(-32%)
Severe decline -20.0%, PE contracts to 23.3
These are projections based on PE multiples and EPS growth scenarios, not predictions. Actual results may vary significantly.
💡
Upside Surprise Potential
If earnings stabilize (0% growth), PE could expand from 8.4 to 8.9
Stabilization Target:
$55.94
(+5.5%)
PE Expansion Potential:
+5.5%
Share & Embed Analysis
Last updated: May 18, 2026 4:15 AM ET
Data refreshes hourly during market hours. Next update: 5:15 AM
Data refreshes hourly during market hours. Next update: 5:15 AM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is SLNO showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
ARGX
argenx NV ADR |
STRONG BUY
22 analysts |
$1022 | 63 BUY |
|
CRSP
Crispr Therapeutics AG |
BUY
28 analysts |
$83 | 50 HOLD |
|
ASND
Ascendis Pharma AS |
STRONG BUY
16 analysts |
$293 | 60 BUY |
|
RCKT
Rocket Pharmaceuticals I… |
STRONG BUY
18 analysts |
$9 | 42 HOLD |
|
VRDN
Viridian Therapeutics Inc |
STRONG BUY
16 analysts |
$34 | 59 HOLD |
Advanced SLNO Option Strategies
Professional options setups generated by AI based on today's SLNO price and gamma walls.
